Sarepta Therapeutics (SRPT) Earnings Date & Reports

Sarepta Therapeutics Inc is a commercial-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, gene therapies, and other genetic medicines for rare diseases, particularly neuromuscular disorders... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

SRPT is expected to report earnings to fall 78.12% to 69 cents per share on August 05

Sarepta Therapeutics SRPT Stock Earnings Reports

Q2'26

Est.

$0.69

Q1'26

Beat

by $2.17

Q4'25

Missed

by $2.37

Q3'25

Beat

by $0.57

Q2'25

Beat

by $1.32

The last earnings report on May 06 showed earnings per share of $3.16, beating the estimate of 99 cents. With 4.08M shares outstanding, the current market capitalization sits at 2.11B.

View a ticker or compare two or three

Compare

SRPT

Setup

Daily Signal:

Description

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for SRPT

A.I. Advisor